Annual report pursuant to Section 13 and 15(d)

Concentrations

v3.7.0.1
Concentrations
12 Months Ended
Dec. 31, 2016
Risks And Uncertainties [Abstract]  
Concentrations

NOTE 9 — CONCENTRATIONS

Revenue from the Company’s products for the years ended December 31, 2016, 2015 and 2014 are as follows:

 

 

 

Years Ended December 31,

 

 

 

 

2016

 

 

2015

 

 

2014

 

 

Laser systems

 

 

67.9

 

%

 

67.5

 

%

 

61.9

 

%

Imaging systems

 

 

5.9

 

%

 

4.6

 

%

 

9.0

 

%

Consumables and other

 

 

13.3

 

%

 

14.2

 

%

 

13.7

 

%

Services

 

 

12.6

 

%

 

13.3

 

%

 

15.1

 

%

License fees and royalties

 

 

0.3

 

%

 

0.4

 

%

 

0.3

 

%

Total revenue

 

 

100.0

 

%

 

100.0

 

%

 

100.0

 

%

 

The Company maintains its cash and cash equivalent accounts with established commercial banks. Such cash deposits periodically exceed the Federal Deposit Insurance Corporation insured limit.

No individual customer represented more than 10% of the Company’s accounts receivable at December 31, 2016 and 2015.

The Company currently purchases certain key components of its products from single suppliers. Although there are a limited number of manufacturers of these key components, management believes that other suppliers could provide similar key components on comparable terms. A change in suppliers, however, could cause delays in manufacturing and a possible loss of sales, which could adversely affect the Company’s business, results of operations and financial condition.